Literature DB >> 21098274

Malignant cells facilitate lung metastasis by bringing their own soil.

Dan G Duda1, Annique M M J Duyverman, Mitsutomo Kohno, Matija Snuderl, Ernst J A Steller, Dai Fukumura, Rakesh K Jain.   

Abstract

Metastatic cancer cells (seeds) preferentially grow in the secondary sites with a permissive microenvironment (soil). We show that the metastatic cells can bring their own soil--stromal components including activated fibroblasts--from the primary site to the lungs. By analyzing the efferent blood from tumors, we found that viability of circulating metastatic cancer cells is higher if they are incorporated in heterotypic tumor-stroma cell fragments. Moreover, we show that these cotraveling stromal cells provide an early growth advantage to the accompanying metastatic cancer cells in the lungs. Consistent with this hypothesis, we demonstrate that partial depletion of the carcinoma-associated fibroblasts, which spontaneously spread to the lung tissue along with metastatic cancer cells, significantly decreases the number of metastases and extends survival after primary tumor resection. Finally, we show that the brain metastases from lung carcinoma and other carcinomas in patients contain carcinoma-associated fibroblasts, in contrast to primary brain tumors or normal brain tissue. Demonstration of the direct involvement of primary tumor stroma in metastasis has important conceptual and clinical implications for the colonization step in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098274      PMCID: PMC3003109          DOI: 10.1073/pnas.1016234107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Illuminating the metastatic process.

Authors:  Erik Sahai
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

2.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis.

Authors:  I J Fidler
Journal:  Eur J Cancer       Date:  1973-03       Impact factor: 9.162

3.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

Authors:  Dan G Duda; Kenneth S Cohen; Sergey V Kozin; Jean Y Perentes; Dai Fukumura; David T Scadden; Rakesh K Jain
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

4.  The significance of hematogenous tumor cell clumps in the metastatic process.

Authors:  L A Liotta; M G Saidel; J Kleinerman
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

5.  Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity.

Authors:  J L Arbiser; G Raab; R M Rohan; S Paul; K Hirschi; E Flynn; E R Price; D E Fisher; C Cohen; M Klagsbrun
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential.

Authors:  T V Updyke; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

7.  C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.

Authors:  Hendrik W van Deventer; Qing Ping Wu; Daniel T Bergstralh; Beckley K Davis; Brian P O'Connor; Jenny P-Y Ting; Jonathan S Serody
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

8.  Tissue-isolated human tumor xenografts in athymic nude mice.

Authors:  P E Kristjansen; S Roberge; I Lee; R K Jain
Journal:  Microvasc Res       Date:  1994-11       Impact factor: 3.514

9.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

10.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

View more
  231 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

Review 2.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

Review 3.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

Review 4.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

Review 5.  Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.

Authors:  Dennis Woo; Min Yu
Journal:  Transl Res       Date:  2018-07-17       Impact factor: 7.012

6.  Establishing In Situ Closed Circuit Perfusion of Lower Abdominal Organs and Hind Limbs in Mice.

Authors:  Fangfang Chen; Dmitri Simberg; Ping Ren; Chunyan Yang; Laren A Lofchy; Guankui Wang
Journal:  J Vis Exp       Date:  2020-08-13       Impact factor: 1.355

7.  Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.

Authors:  Ivy X Chen; Vikash P Chauhan; Jessica Posada; Mei R Ng; Michelle W Wu; Pichet Adstamongkonkul; Peigen Huang; Neal Lindeman; Robert Langer; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-30       Impact factor: 11.205

Review 8.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

Authors:  Daniel A Haber; Victor E Velculescu
Journal:  Cancer Discov       Date:  2014-05-06       Impact factor: 39.397

Review 9.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08

10.  EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Authors:  Elisa Giannoni; Maria Letizia Taddei; Matteo Parri; Francesca Bianchini; Michela Santosuosso; Renata Grifantini; Gabriella Fibbi; Benedetta Mazzanti; Lido Calorini; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.